1. Home
  2. FCF vs HRMY Comparison

FCF vs HRMY Comparison

Compare FCF & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Commonwealth Financial Corporation

FCF

First Commonwealth Financial Corporation

HOLD

Current Price

$19.52

Market Cap

1.9B

Sector

Finance

ML Signal

HOLD

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$33.43

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FCF
HRMY
Founded
1934
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.8B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
FCF
HRMY
Price
$19.52
$33.43
Analyst Decision
Buy
Buy
Analyst Count
4
9
Target Price
$19.75
$44.11
AVG Volume (30 Days)
629.3K
718.4K
Earning Date
04-28-2026
05-07-2026
Dividend Yield
2.94%
N/A
EPS Growth
5.76
7.97
EPS
0.37
0.55
Revenue
N/A
$868,453,000.00
Revenue This Year
$16.32
$19.75
Revenue Next Year
$6.25
$12.88
P/E Ratio
$52.64
$60.29
Revenue Growth
N/A
21.51
52 Week Low
$15.00
$25.52
52 Week High
$20.05
$40.87

Technical Indicators

Market Signals
Indicator
FCF
HRMY
Relative Strength Index (RSI) 59.54 55.65
Support Level $18.07 $31.61
Resistance Level N/A $35.47
Average True Range (ATR) 0.37 1.14
MACD 0.03 0.04
Stochastic Oscillator 66.13 52.57

Price Performance

Historical Comparison
FCF
HRMY

About FCF First Commonwealth Financial Corporation

First Commonwealth Financial Corp functions in the financial services sector in the United States. Through its subsidiary, it offers a range of consumer and commercial banking services such as personal checking accounts, interest-earning checking accounts, savings accounts, insured money market accounts, investment certificates, fixed & variable rate certificates of deposit, and various kinds of loans. It also provides trust and wealth management services and offers insurance products. The company earns the majority of its revenue through net interest income.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: